Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema-Reference-Cited by-同舟云学术

Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema

Published:2020-09 Issue:3 Volume:125 Page:334-340.e1
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Bernstein Jonathan A.,Schwartz Lawrence,Yang William,Baker James,Anderson John,Farkas Henriette,Aygören-Pürsün Emel,Bygum Anette,Jacobs Iris,Feuersenger Henrike,Pragst Ingo,Riedl Marc A.

Funder

Shire

CSL Behring

BioCryst

Swedish Orphan Biovitrum

Takeda

Arrowhead

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference25 articles.

1. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients;Agostoni;Medicine (Baltimore),1992

2. Hereditary angioedema: new findings concerning symptoms, affected organs, and course;Bork;Am J Med,2006

3. Clinical practice. Hereditary angioedema;Zuraw;N Engl J Med,2008

4. Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies;Aygören-Pürsün;Orphanet J Rare Dis,2018

5. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency;Farkas;Allergy,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Therapeutics in Hereditary Angioedema;Immunology and Allergy Clinics of North America;2024-08

2. The Crystal Structure of the Michaelis–Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation;The Journal of Immunology;2024-07-12

3. Interventions for the long-term prevention of hereditary angioedema attacks;Cochrane Database of Systematic Reviews;2022-11-03

4. Hereditary Angioedema: Diagnosis, Pathogenesis, and Therapy;Current Treatment Options in Allergy;2022-07-02

5. Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management;Clinical Therapeutics;2021-12